Filtros

Buscador
Año
Pons-Fuster E, Bernal E, Guillamon CF, Gimeno L, Martinez-Sanchez MV, Ruiz-Lorente I, Campillo JA, Ceballos D, Torres A, Tomas C, Munoz A, Alcaraz A, Selma P, Ruiz-Nicolas C, Muro M, Minguela A. HLA-C*07 is associated with symptomatic HIV-1-associated neurocognitive disorders (HAND) and immune dysregulation. Infect Dis (Lond). 2024 Oct;56(10):818-829. doi: 10.1080/23744235.2024.2351047. Epub 2024 May 14. PubMed PMID: 38743055.
AÑO: 2024; IF: 2.3
Chalkias A, Huang Y, Ismail A, Pantazopoulos I, Papagiannakis N, Bitterman B, Anderson E, Catalan T, Erne GK, Tilley CR, Alaka A, Amadi KM, Presswalla F, Blakely P, Bernal-Morell E, Cebreiros Lopez I, Eugen-Olsen J, Garcia de Guadiana Romualdo L, Giamarellos-Bourboulis EJ, Loosen SH, Reiser J, Tacke F, Skoulakis A, Laou E, Banerjee M, Pop-Busui R, Hayek SS; International Study of Inflammation in COVID-19 (ISIC) Investigator Group. Intubation Decision Based on Illness Severity and Mortality in COVID-19: An International Study. Crit Care Med. 2024 Jun 1;52(6):930-941. doi: 10.1097/CCM.0000000000006229. Epub 2024 Feb 23. PubMed PMID: 38391282.
AÑO: 2024; IF: 6.0
Autores:
Ruzafa Martinez C, Valero S, Garcia Villalba E, Tomas C, Munoz A, Alcaraz A, Martinez-Rodriguez R, Hernandez MD, Martinez MI, Vicente MR, Guijarro Westermeyer E, Gonzalez Hipolito R, Bernal E. Vaccine effectiveness in patients admitted for influenza during the 2023-2024 season. Med Clin (Barc). 2024 Dec 27;163(12):589-594. doi: 10.1016/j.medcli.2024.07.023. Epub 2024 Oct 15. English, Spanish. PubMed PMID: 39414550.
AÑO: 2024; IF: 2.1
Autores:
Moreno C, Izquierdo R, Alejos B, Hernando V, Perez de la Camara S, Peraire J, Macias J, Bernal E, Albendin-Iglesias H, Alcaraz B, Suarez-Garcia I, Moreno S, Jarrin I; CoRIS Cohort. Acceptability of Long-Acting Injectable Antiretroviral Treatment for HIV Management: Perspectives of Patients and Physicians in Spain. AIDS Patient Care STDS. 2024 Jul;38(7):305-314. doi: 10.1089/apc.2024.0093. Epub 2024 Jun 25. PubMed PMID: 38916077.
AÑO: 2024; IF: 3.8
Autores:
Pons-Fuster E, Martinez-Rodriguez R, Gimeno-Arias L, Alcaraz MJ, Moreno M, Gomez JM, Pelaez A, Garcia E, Tomas C, Munoz A, Martinez-Sanchez MV, Ruiz-Lorente I, Ceballos D, Minguela A, Bernal E. HLA-A*03 may confer protection against long COVID through an enhanced immune response. Infect Dis Now. 2025 Mar 17:105057. doi: 10.1016/j.idnow.2025.105057. Online ahead of print. PubMed PMID: 40107360.
AÑO: 2025; IF: 2.2
Autores: